載入...
Efficacy of icotinib in advanced lung squamous cell carcinoma
BACKGROUND: There are controversial data supporting the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with advanced lung squamous cell carcinoma (SCC). In this study, the efficacy of icotinib in unselected and EGFR‐mutated patients with lung SCC wa...
Na minha lista:
| 發表在: | Cancer Med |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6143949/ https://ncbi.nlm.nih.gov/pubmed/30109777 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1736 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|